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ABSTRACT 
Objective: p-Phenylenediamine (PPD) is a possible contact sensitizer in skin tissues; however, data are lacking regarding its specific effects on nitric 
oxide synthase (NOS) expression during the sensitization phase. The purpose of this study was to investigate nNOS and iNOS expression in the skin 
tissue of PPD-treated mice.  
Methods: BALB/c mice were dermally exposed to PPD, at a dose of 10 or 50 mg/kg, on three occasions. The ear and dorsal skin tissues were then 
isolated from PPD-treated mice and vehicle-treated controls. Western blot analyses were performed on samples derived from the skin tissues. 
Results: The dorsal skin tissues of PPD-treated BALB/c mice showed significantly increased levels of iNOS. However, nNOS expression in dorsal 
skin, and nNOS and iNOS expression in the ear, was not significantly altered in PPD-treated skin tissues compared to controls.  
Conclusion: Because enhanced expression of iNOS may contribute to inflammation in allergic contact dermatitis, our data suggest that increased 
levels of iNOS may be involved in early immunological responses to PPD-induced pathogenesis in dorsal skin. 
Keywords: Nitric oxide synthase, p-phenylenediamine, Dorsal skin, Ear, Sensitization. 
 
p-Phenylenediamine (PPD) is an aromatic amine component of 
oxidative hair dyes, widely used as an active ingredient in such 
products in numerous countries [1]. PPD is estimated to be present 
in approximately 70% of hair dyes worldwide; these dyes represent 
the most common source of exposure to PPD [2, 3]. However, PPD is 
known to possess extreme sensitizing potency [4]. In one study, 
cases that had adverse reactions to hair dyes were all positive for 
PPD in patch tests [5]. Furthermore, PPD is a recognized, potent 
sensitizer that may lead to allergic contact dermatitis (ACD) [6, 7].  
ACD is an immunologically mediated inflammatory dermatosis; 
nitric oxide (NO) is known to be involved in the pathogenesis of 
acute and chronic inflammatory conditions, including ACD [8, 9]. NO 
is produced from -arginine in a reaction catalyzed by nitric oxide 
synthase (NOS) enzymes [10, 11]. There are three isomeric forms of 
NOS: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS) 
types [12]. The calcium-dependent nNOS and eNOS enzymes 
produce low levels of NO, whereas iNOS generates markedly higher 
levels in a calcium-independent manner [13, 14]. All three NOS iso 
forms are expressed in various cell types located in the skin, 
including keratinocytes [15,16]. Among the NOS enzymes, iNOS is 
considered to be most-involved in inflammatory and pathological 
conditions [12]. Particularly in the skin, NO produced by iNOS 
mediates various physiological functions, ranging from the 
regulation of cutaneous blood flow to melanogenesis [17]; it also 
modulates antigen presentation [18]. Furthermore, a previous study 
has demonstrated that nNOS plays a role in autoimmune skin 
diseases such as pemphigus vulgaris [19]. Furthermore, NO 
generated by epidermal nNOS plays a significant role in cutaneous 
circulatory responses to mechanical stimulation [20]. 
Therefore, the present study was undertaken to determine whether 
topical application of PPD could change the expression of nNOS and 
iNOS in the ear and dorsal skin of mice. Using protein immuno blot 
methods, we investigated the effects of PPD on nNOS and iNOS 
expression.  
BALB/c mice (n = 12, 9-w--old females; weight = 19.5±1.0 g) were 
divided into vehicle-treated control, 10 mg/kg PPD-treated, and 50 
mg/kg PPD-treated groups. Animals in the control, 10 mg/kg PPD, 
and 50 mg/kg PPD treatment groups were contact-sensitized by 
topical application of acetone in olive oil (1:4), 10 mg/kg PPD, and 
50 mg/kg PPD, respectively. Mice were sensitized on a shaved area 
of the ear and dorsal skin, once per day for 3 d. All animals were 
euthanized 5 h after the last treatment. The mice were purchased 
from Samtako (Osan, Korea); PPD (fig. 1) was purchased from Sigma 
(St Louis, MO, USA). Other reagents, of the highest available quality, 
were obtained from commercial sources. All experiments were 
approved by the Institutional Animal Care and Use Committee of 
Keimyung University, Korea. Experiments were conducted in 
accordance with the National Institutes of Health guidelines for the 
care and use of laboratory animals. Animals were housed in a specific 
pathogen-free (SPF) facility, with free access to food and water.  
 
 
Fig. 1: The structure of p-phenylenediamine 
 
Five hours after the treatment regimen ended, mice were euthanized 
by CO2 asphyxiation, and the ear and dorsal skin tissues were 
removed rapidly on ice. Tissue samples were immediately placed 
into cryovials and stored at-70 °C until use. For Western blotting, 
tissues were homogenized in RIPA buffer (Sigma) containing 1% 
protease inhibitor and phosphatase inhibitor cocktails. The 
homogenate was centrifuged (14,000 rpm, 40 min) and the 
supernatant collected. The protein concentration was estimated 
using the Bradford method, with bovine serum albumin (BSA) used 
as the standard. An aliquot (5-μg protein) was subjected to 10% 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE), and the fractionated proteins were then transferred to 
a nitrocellulose membrane. For immuno blotting, the following 
primary antibodies were used: mouse anti-nNOS monoclonal 
antibody (1:10,000 dilution; Santa Cruz Biotechnology, CA, USA) and 
mouse anti-iNOS monoclonal antibody (1:1000 dilution; Santa Cruz 
Biotechnology). After incubation with HRP-conjugated secondary 
antibodies (Amersham Biosciences, NJ, USA), the immunoreactive 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                  Vol 7, Issue 8, 2015 
Innovare 
Academic Sciences 
Kim et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 8, 212-215 
213 
bands were visualized using ECL Western blotting detection 
reagents (Amersham Biosciences) and X-ray film. Band intensity was 
measured using the ImageJ program (NIH, Bethesda, MD, USA). 
GAPDH was used as a control for immuno blotting. 
Densitometric measurements of nNOS and iNOS protein expression in 
PPD-treated animals were compared with those of controls using 
one-way analysis of variance, followed by a post hoc Duncan test. A P 
value<0.05 was taken to indicate statistical significance. Data are 
presented as means±SEM. All statistical analyses were conducted using 
the SAS software package (ver. 9.2; SAS Institute Inc., Cary, NC, USA). To 
elucidate the effect of PPD, nNOS and iNOS expression in the dorsal 
skin was compared between control and PPD-treated mice: PPD 
exposure increased iNOS expression in a dose-dependent manner; 
exposure to higher-dose PPD induced significant increases in iNOS 
expression (P<0.05). However, nNOS expression was not significantly 




Fig. 2: Relative expression levels of nNOS (a) and iNOS (b) in the dorsal skin tissues of mice treated with 10 or 50 mg/kg PPD. Each panel 
shows a representative Western blot (top) and densitometric band analysis in the control and PPD-treated groups (bottom). Values 
represent means±SEM in each group (n = 4). *p<0.05, compared with the control group 
 
nNOS and iNOS expression were also evaluated in PPD-treated ear tissues. Unlike iNOS expression in the dorsal skin, PPD had no significant overall 
effect on iNOS expression in the ear tissues of treated mice (P = 0.0531). Moreover, nNOS expression was not significantly altered by treatment with 




Fig. 3: Relative expression levels of nNOS (a) and iNOS (b) in the ear tissues of mice treated with 10 or 50 mg/kg PPD. Each panel shows a 
representative Western blot (top) and densitometric band analysis in the control and PPD-treated groups (bottom). Values represent 
means±SEM in each group (n = 4) 
 
PPD exposure is known to cause hypersensitivity, which is 
characterized by a number of biochemical processes that result in 
contact dermatitis [21]. Although a wide range of effects on 
immunological signal transduction during hypersensitivity reactions 
have been reported, the specific effects of PPD on NOS expression 
are not fully understood.  
Therefore, in this study we investigated the effects of PPD exposure 
on nNOS and iNOS expression in the ears and dorsal skin of mice. 
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NO is an important mediator in skin biology, and is also involved in 
inflammatory skin disorders including wound healing, burn injuries, 
ultraviolet light-induced sunburn erythema, psoriasis, and contact 
dermatitis [22–26]. Exposure of the skin to chemical irritants results 
in higher levels of NO synthesis and the production of 
pro-inflammatory cytokines [27]. NO is formed in a reaction 
catalyzed by NOS enzymes. The major cell types that comprise the 
skin, including keratinocytes, fibroblasts, melanocytes, and 
endothelial cells, all express NOS. Keratinocytes account for 
approximately 90–95 % of the cells in the epidermis that 
constitutively express nNOS [23, 25]. Keratinocytes are also known 
to express iNOS message and protein following exposure to 
inflammatory cytokines [23, 28].  
Our data show that iNOS expression levels are increased 
significantly by exposure to 50 mg/kg PPD in dorsal skin. The 
expression of iNOS may influence several immunologic reactions in 
the skin; iNOS expression is observed in a number of inflammatory 
skin conditions including psoriasis, atopic dermatitis, irritant 
contact dermatitis and ACD [29, 30]. Moreover, high levels of iNOS 
expression have been observed in the skin of patients with Sjögren’s 
syndrome, which is associated with photosensitivity [31]. Because 
prolonged exposure to PPD is known to cause ACD, our findings 
suggest a possible role of iNOS in the pathogenesis of ACD induced 
by PPD exposure.  
Our data on iNOS demonstrate a difference in expression patterns 
between the ear and dorsal skin following PPD treatment. Therefore, 
the effect of PPD on NOS expression may differ according to skin 
type. One possible explanation for these differences among skin 
regions is that the rate of diffusion may play an important role in 
determining the level of iNOS expression. Differences in diffusion 
rates may be caused by skin tissue structure differences. In the ear, 
connective tissues under the dermis are tightly bound, and the 
elasticity of the skin is low. However, dorsal skin, which contains an 
abundance of fatty tissues within the subcutaneous connective 
tissues, is more loose and elastic [32]. Because of such differences, 
PPD administered to dorsal skin might be rapidly diffused between 
the subcutaneous tissues and muscle layers. Therefore, iNOS 
expression following PPD administration may be influenced by 
retention time differences between ear and dorsal skin. 
In conclusion, PPD exposure induced differential iNOS expression 
patterns between the ear and dorsal skin, whereas nNOS expression 
remained unaltered in both ear and dorsal skin tissues. In the dorsal 
skin, iNOS expression was significantly increased in the high-dose 
PPD group. These data indicate that altered iNOS homeostasis in the 
dorsal skin may contribute to PPD-induced dermato toxicity. 
However, further studies, including measurements of NO and/or 
other signaling molecules, are required to fully address the effects of 
PPD on NO-mediated signal transduction and inflammation. 
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